10x基因组学 TXG
$59.28 +$1.22 (+2.10%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $61.20 +3.24%
开盘$57.89
昨收$58.06
当日区间$55.50 – $61.99
成交量4.52M
市值$7.72B
市盈率（TTM）–
股息率–
财报
财报日平均波动±6.6%近16次财报
收涨次数11 / 1669% 的概率
最佳反应+18.5%
最差反应-8.1%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 6 Aug 2026 | After Market | ±13.7% | +14.10% | 超出定价预期 |
| 2026/Q1 | 7 May 2026 | After Market | ±13.2% | -3.66% | 符合区间 |
| 2025/Q4 | 12 Feb 2026 | After Market | ±16.0% | +3.48% | 符合区间 |
| 2025/Q3 | 6 Nov 2025 | After Market | ±21.6% | +17.31% | 符合区间 |
| 2025/Q2 | 7 Aug 2025 | After Market | ±21.0% | -3.98% | 符合区间 |
| 2025/Q1 | 8 May 2025 | After Market | ±30.3% | +1.62% | 符合区间 |
| 2024/Q4 | 12 Feb 2025 | After Market | ±18.8% | -0.50% | 符合区间 |
| 2024/Q3 | 29 Oct 2024 | After Market | ±20.3% | +4.43% | 符合区间 |
| 2024/Q2 | 8 Aug 2024 | After Market | ±15.9% | +4.50% | 符合区间 |
| 2024/Q1 | 30 Apr 2024 | After Market | ±17.3% | -8.06% | 符合区间 |
| 2023/Q4 | 15 Feb 2024 | After Market | ±17.1% | +0.79% | 符合区间 |
| 2023/Q3 | 2 Nov 2023 | After Market | ±15.1% | +8.73% | 符合区间 |
| 2023/Q2 | 3 Aug 2023 | After Market | ±13.4% | -4.19% | 符合区间 |
| 2023/Q1 | 3 May 2023 | After Market | ±14.6% | +1.30% | 符合区间 |
| 2022/Q4 | 15 Feb 2023 | After Market | ±13.1% | +11.15% | 符合区间 |
| 2022/Q3 | 2 Nov 2022 | After Market | ±32.6% | +18.50% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$151.04M-12.6% YoY
营业利润-$22.96M-117.1% YoY
净利润-$17.93M-151.9% YoY
摊薄每股收益-$0.14-150.5% YoY
自由现金流$15.39M-4.6% YoY
经营现金流$16.97M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率70.0%
营业利润率-14.9%
净利率-12.2%
净资产收益率-9.4%
资产收益率-7.5%
投入资本回报率-10.0%
流动比率5.69
负债/资产比率19.9%
现金及投资$552.03M
总负债$66.78M
净现金（净负债）$485.25M
自由现金流/营收19.7%
暂无评论——快来第一个聊聊 TXG。
登录后参与讨论。